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exposed users were similar to results for all users. CONCLUSIONS: Inappropriate 
prescribing in the elderly contributes to negative clinical and economic 
outcomes. Specific interventions have been utilized to decrease incidence of 
inappropriate prescribing, but there is little evidence on the long-term 
sustainability of such project effects. The significant reductions in PIM exposure 
after our intervention appear to have continued after its discontinuation, 
supporting the idea that the intervention concretely impacted GPs’ prescribing 
behavior. Patient and GP characteristics did not contribute to the effect of the 
intervention.  
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OBJECTIVES: During the 1990s, U.S. outpatient antibiotic utilization declined 
after the launch of national educational campaigns; however, it is unknown if 
these trends were sustained in the last decade. The purpose of this study was to 
describe U.S. antibiotic prescribing trends from 2000 to 2010. METHODS: This 
was a retrospective analysis of nationally representative data from the Medical 
Expenditure Panel Survey (MEPS) from 2000 to 2010. Trends in population-based 
prescribing were examined for overall antibiotics and for non-otitis media (non-
OM) respiratory tract infections (RTIs) [bronchitis, pharyngitis, sinusitis, and 
upper-RTIs as defined by ICD-9-CM codes 460-463, 465, 466, 473, and 490]. Rates 
were reported for three age groups: children and adolescents (younger than 18 
years), adults (18-64 years), and older adults (≥65 years). Antibiotic prescriptions 
were identified using the Lexicon Multum classification system. Population 
estimates were obtained from the U.S. Census Bureau, and annual rates were 
reported per 1,000 persons. RESULTS: The overall annual rate of antibiotic 
prescriptions decreased from 377 per 1000 persons in 2000 to 365 per 1,000 
persons in 2010. Among children and adolescents, the overall and non-OM RTI 
antibiotic prescribing rates decreased by 19% and 12%, respectively. Both rates 
remained stable in adults. In contrast, the overall and non-OM RTI antibiotic 
prescribing rates increased by 16% and 7%, respectively, in older adults. This 
increase was attributed to a 30% increase in the use of fluoroquinolones and 
second-generation macrolides over the study period. CONCLUSIONS: Overall, 
antibiotic prescribing has decreased in the U.S. population over the last decade. 
This decrease has mostly occurred in children and adolescents while older 
adults have actually experienced an increase in antibiotic prescribing. Focused 
public policy initiatives are needed to promote the judicious use of antibiotics in 
older adults.  
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OBJECTIVES: The relationship between inequities in socioeconomic factors (i.e. 
poverty) and adverse health outcomes has being studied before, but most studies 
were aggregated by country. A further disaggregation may contribute to causality 
and may help explain the within country differences and lack of improvements 
of some health indexes. In order to assess inequalities in Colombia this study 
evaluate by geographical region (state) of the infant mortality rate in Colombia in 
1993 and 2005, the two years where the census took place. METHODS: This 
ecological study measures regional inequalities in the infant mortality rate (IMR), 
using these indexes: Rate difference (RD), incidence rate ratio (IRR) and 
population attributable risk (PAR). Poverty was measured as the index of 
unsatisfied needs (Necesidades Básicas Insatisfechas, NBI). A linear regression 
was made for the association between IMR and NBI (poverty), and beta-
coefficients with 95% confidence intervals (95%CI) were estimated. RESULTS: In 
1993, the absolute difference between regions (states) with more and less poverty 
(Chocó: 80.4%; Bogotá, D.C.:17.3%) was 63.1%. In 2005, this difference was 70.4%. 
For these years, the IRR of IMR between those (Choco and Bogota) states was 2.9 
y 4.2 and RD 56.4 y 59.2, respectively. The R-square between poverty and IMR 
was in 2005 63.8%, versus a R-square of 34.2% for 1993. The beta-coefficient of 
linear regression was 0.339 for 1993 (IC 95%, 0.167-0.552). For each perceptual 
point that decreases poverty in the states, a reduction of TMI by 0.339 for each 
1,000 live births. In 2005, this reduction was 0.646 for each 1,000 live births (IC 
95%, 0.468-0.823). CONCLUSIONS: Although Colombia has a trend of TMI 
reduction, health inequalities persist between states in the country. These 
inequalities increased between 1993 and 2005.  
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OBJECTIVES: An aging population translates into an increase in drug use, while 
medication management is challenged by the uniqueness of geriatric 
pharmacology. Our objective is to understand the most frequent IMUs dispensed 
from community pharmacies. METHODS: We used Beers’ 2002 Criteria 
(regardless of diagnoses and conditions) in our analysis. The prescription 
repository from a downtown community pharmacy (Yalova, Turkey) with  
a diverse socio-economic demographic profile was retrospectively monitored to 
identify IMU. The Social Security Institution (SGK)’s “Medula” database  
was utilized to identify patients to whom at least one prescription was dispensed 
in the month of October 2011. The patient records were tracked back to  
the period between September and November 2011 to analyze their prescriptions 
details. SGK-Medula prescriptions for 192 elderly patients (≥60 years-old)  
were identified (108 female and 84 male). RESULTS: From data analysis, 424 
cases of IMU were identified. Each patient was exposed on average to 2.2 IMUs. 
The majority (61.8%) of all IMU cases involved non steroidal anti-inflammatory 
drugs (NSAID). The average use of NSAID per patient was 1.36. There was  
no statistically significant difference between female and male NSAID IMU.  
The second most IMU was chlorpheniramine usage, with 9% of all IMU  
cases; again no statistically significant difference was found between females 
and males. The third most frequently observed IMU involved nitrofurantoin  
in males (13.1%), and hydroxyzine in females (10.2%). Regardless of gender, 
ferrous sulphate (4.0%) was ranked the third overall most recorded  
IMU. Stimulant laxatives, alprazolam, doxazosin, and ticlopidine were also 
among the frequently observed IMU cases in this study. CONCLUSIONS: 
Prescriptions for the elderly should be systematically evaluated to check for  
IMU. NSAIDs, chlorpheniramine, nitrofurantoin, hydroxyzine, and ferrous 
sulphate may be especially worrisome due to high prevalence of exposure to 
these agents.  
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OBJECTIVES: Seasonal flu vaccine uptake rates among socioeconomically 
disadvantaged children have been documented, but not much is known about 
the relationship between doctor’s recommendation for seasonal and H1N1 flu 
vaccines. During the 2009-2010 flu season, persons had access to two separate 
influenza vaccines to prevent H1N1- and seasonal flu-related complications. The 
study explored the impact of doctor’s recommendations for seasonal and H1N1 
flu vaccines on Medicaid/State Children’s Health Insurance Program (SCHIP)-
covered children’s seasonal and H1N1 flu vaccination. The hypothesis to be 
tested was that a doctor’s recommendation increases vaccine uptake for both 
vaccines. The current study addressed different marginal effects estimates from 
the bivariate model identification to characterize this hypothesis. METHODS: 
This study used the Centers for Disease Control and Prevention National 2009 
H1N1 Flu Survey and focused on the nationally representative subsample of 1794 
Medicaid/SCHIP children between the ages of 6 months to 17 years old.  
A bivariate probit model was used to jointly estimate the effects of doctors’ 
recommendations on seasonal and H1N1 flu vaccination. The model controlled 
for age, race, gender, household income, census region, number of household 
children, and past sickness. RESULTS: The choice framework resulted in  
a significant estimation of rho=0.532 (p=0.000) suggesting a positive correlation 
between the outcomes of seasonal and H1N1 vaccination. The average marginal 
effect from the bivariate probit model estimated that Medicaid/SCHIP children 
receiving a doctor’s recommendation for both, seasonal, and H1N1 were 34.5% 
(p=0.000), 11.5% (p=0.000), 14.1% (p=0.000), respectively, more likely to acquire 
seasonal and H1N1 flu vaccinations versus a doctor’s recommendation  
for neither. CONCLUSIONS: The results suggest a doctor’s recommendation  
was influential for vaccine uptake for Medicaid/SCHIP covered children during 
the 2009-2010 flu season. The findings suggest doctor’s recommendation  
should be an important factor in policy efforts to address barriers to flu 
vaccination.  
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OBJECTIVES: To determine 1) between-hospital variation in bronchodilator (BD) 
and inhaled corticosteroid (ICS) use for preterm infants with bronchopulmonary 
dysplasia (BPD) including hospital-specific treatment frequency, and 2) 
demographic and clinical variables associated with diuretic administration. 
METHODS: A retrospective cohort investigation was conducted using the 
Pediatric Health Information System (PHIS) database to determine between-
hospital variation in BD (Beta2-agonists; ipratroprium) and ICS utilization, as 
well as variables associated with their administration, among infants with 
evolving BPD at 28 days of age, born at 35 U.S. children's hospitals between 
January 2007-June 2011. Inclusion criteria: <29 weeks gestation, <1.5 kgs 
birthweight, survived 28 days, and on oxygen, CPAP, and/or ventilation for ≥28 
consecutive days. Between-hospital percent-use comparisons were limited to 
hospitals with >25 included infants to prevent overweighting of smaller-samples. 
RESULTS: During the 54-month study period, 1429 infants were identified with 
evolving BPD, of which 544 (38%) received bronchodilators (BDs) and 352 (25%) 
received ICS. Hospitals differed significantly in the use of BDs [intraclass 
correlation coefficient (ICC): 0.35] and ICS (ICC: 0.42) even after controlling for 
observed confounders with multilevel, multivariable logistic regression. By 
hospital (N=15), the percentage of patients that ever received these medications 
ranged from 5-81% (median:33; IQR:8%-56%) for BDs and from 0-60% (12; 2-35%) 
for ICS. At 3 hospitals (20%) no patients received ICS. Risk factors significantly 
associated with bronchodilator administration included: increasing length of 
mechanical ventilation, birth weight 500-749 grams (reference group: 1000-1499 
